COCP - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Cocrystal

Cocrystal Pharma, Inc. (COCP) delegates drug production and testing to external contractors, as it does not own its own manufacturing plants. Experienced management focuses on patents and clinical development. GURU.Markets clearly illustrates comparable quarterly EPS growth, and the current parameter is -13.60. The company is currently undergoing early-stage trials, competing with other biotech startups to attract investment capital.

Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan cocrystalpharma.com (COCP): kanggo periode 04.07.2022 - 14.11.2026

Rincian analitis perusahaan Cocrystal Pharma, Inc.

- nilai pasar lan prakiraan target analis:

Bagan rega Cocrystal|COCP - Konsensus nilai wajar

- statistik kapitalisasi pasar:

Biji pasar Cocrystal Pharma Corp|COCP - Nilai Perusahaan

- indikator kapitalisasi buku:

Aset Bersih saben Siji Saham Cocrystal Pharma|COCP - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku cocrystalpharma.com|COCP - Gunggung Aset Perusahaan

- data utang lan likuiditas:

Utang marang Ekuitas Cocrystal Pharma, Inc.|COCP - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Cocrystal Pharma Inc|COCP - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Cocrystal Pharma, Inc.|COCP - Silihan lan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Cocrystal Pharma|Likuiditas cepet cocrystalpharma.com

- rincian bathi lan kelipatan pasar:

COCP - Asil keuangan resik|Bathi mangsa ngarep Cocrystal Pharma, Inc.|COCP - Rasio rega pasar marang bathi resik|Pangali Forward P/E Cocrystal Pharma Corp|COCP - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Cocrystal Pharma|COCP - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Cocrystal Pharma|COCP - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan cocrystalpharma.com|COCP - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Cocrystal Pharma, Inc.

- data dodolan lan asil:

COCP - Pendapatan dodolan perusahaan|Prakiraan volume dodolan Cocrystal Pharma Inc|COCP - Multiplikator P/S|Rasio rega marang prakiraan pendapatan Cocrystal Pharma, Inc.

Analisis dhasar perusahaan:Cocrystal Pharma, Inc.

Produk asil prodhuksi Cocrystal Pharma Corp

This indicator measures the quarterly dynamics of earnings per share, reflecting the actual efficiency of capital generation and the pace of business scaling. By analyzing the quarter-over-quarter EPS growth rate, an investor can assess the financial stability of Cocrystal Pharma, Inc. (COCP), where an increase in this metric would confirm the monetization of innovations in the crystalline structure of drugs and the company's future pricing power in the pharmaceutical market.

Karo sapa Cocrystal Pharma, Inc. saingan